Diabetic Neuropathy in Spinal Cord Stimulator Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Chicago

About this trial

The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with DM type 2 of more than 1-year duration

DM stage 3 or less

Patients ≥18 years of age

Refractory painful diabetic peripheral neuropathy of the lower extremities

Disqualifiers

Patients on anticoagulants

Patients with active infections

Patients with HbA1>10

Psychiatric disorders and cognitive dysfunctions

Trial population

Patients that have been seen in the diabetic foot clinic will be evaluated for participation in the study once they have been referred to one of our pain clinics. The study will focus on enrolling patients in early stages of DM 2 with no neuropathic ulcers or arterial calcification.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

25 Participants
are grouped into 1 trial group
Group A: Diabetic patients receiving a spinal cord stimulator

Trial outcomes

Primary outcomes

1

Improve vascular changes

Improve vascular changes (macroscopic: color, edema, ulceration, etc)

Time frame
6 Weeks
2

Vascular improvement on lower extremities with the Ankle Brachial Index (ABI)

Collect data on possible macrovascular improvement in lower extremities by performing the ABI test

Time frame
6 weeks
3

Vascular improvement on lower extremities with the Toe Brachial Index (TBI)

Collect data on possible macrovascular improvement in lower extremities by performing the TBI test

Time frame
6 Weeks
4

Vascular improvement on lower extremities with the Doppler Flowmetry

Collect data on possible macrovascular improvement in lower extremities by performing the Doppler Flowmetry

Time frame
6 Weeks

Secondary outcomes

1

Show Improvement in pain in patients with painful diabetic neuropathy

Improve pain in patients with painful diabetic neuropathy by using the Numeric Rating Scale (NRS) that ranges from 0-10 on the pain scale.

Time frame
6 Weeks
2

Patients' Global Impression of Change (PGIC)

Patient satisfaction using PGIC from baseline to 6 weeks

Time frame
6 Weeks
3

Health-related quality of life (H-RQol)

Quality of life from baseline to 6 weeks

Time frame
6 Weeks
4

Oswestry Low Back Pain Disability Questionnaire (ODI)

Functional capacity using the ODI from baseline to 6 weeks

Time frame
6 Weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.